Cordyceps Research: What Does the Evidence Show?

Cordyceps is marketed with some of the boldest claims in the functional mushroom world. This research summary takes a careful look at what has been studied and what can reasonably be concluded.

The research question

Researchers have asked whether Cordyceps, or compounds such as cordycepin, show measurable biological activity in cells, animals and people.

Why researchers are interested

The long cultural history of the Himalayan caterpillar fungus, the unusual chemistry of Cordyceps militaris, including cordycepin, and the ability to cultivate C. militaris have all driven research.

A complicated picture: which Cordyceps?

Studies have used:

• wild Ophiocordyceps sinensis;
• cultivated Cordyceps militaris fruiting bodies;
• fermented mycelium strains, sometimes labelled as Cordyceps sinensis;
• purified cordycepin.

These are different materials with different chemistry. See Cordyceps militaris vs Ophiocordyceps sinensis.

Study types

• Laboratory studies, particularly of cordycepin, are numerous.
• Animal studies have tested extracts and compounds, often in forms and amounts unlike human use.
• Human studies are relatively few, generally small and short, and use varied preparations, with mixed results.

Limitations

• Different species and materials make studies hard to compare.
• Many human studies are small, short or poorly controlled.
• Materials are often poorly characterised.
• Laboratory findings for purified compounds may not apply to whole extracts.

What we can reasonably conclude

Cordyceps is an active research area, but the evidence doesn’t support specific claims about what Cordyceps products do in people. No health claims are authorised for Cordyceps in the UK.

What remains uncertain

Which species, preparations and compounds, if any, have meaningful effects in people, and in what amounts.

See also How to Read Mushroom Research.